• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

房间隔分流装置治疗心力衰竭。

Interatrial shunt devices for the treatment of heart failure.

机构信息

The Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Cardiovascular Research Foundation, New York, NY, USA.

出版信息

Trends Cardiovasc Med. 2021 Oct;31(7):427-432. doi: 10.1016/j.tcm.2020.09.004. Epub 2020 Oct 3.

DOI:10.1016/j.tcm.2020.09.004
PMID:33022385
Abstract

Despite ongoing advances in the treatment of heart failure, overall symptom burden remains high. Underlying the primary symptom of dyspnea are often elevations in left atrial pressures, which occur across the spectrum of heart failure subgroups. Current therapies do not directly address improvements in left atrial pressures; however, passive left atrial decompression may offer a new avenue to treat heart failure. New technologies are currently being evaluated in clinical testing and may offer a novel therapeutic approach to heart failure.

摘要

尽管心力衰竭的治疗不断取得进展,但整体症状负担仍然很高。呼吸困难的主要症状背后通常是左心房压力升高,这种情况发生在心力衰竭亚组的整个范围内。目前的治疗方法并不能直接解决左心房压力的改善问题;然而,被动左心房减压可能为治疗心力衰竭提供新的途径。新技术目前正在临床测试中进行评估,可能为心力衰竭提供一种新的治疗方法。

相似文献

1
Interatrial shunt devices for the treatment of heart failure.房间隔分流装置治疗心力衰竭。
Trends Cardiovasc Med. 2021 Oct;31(7):427-432. doi: 10.1016/j.tcm.2020.09.004. Epub 2020 Oct 3.
2
Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.创建限制型左向右心房间隔分流术:心力衰竭的一种新治疗方法。
Heart Fail Rev. 2018 Nov;23(6):841-847. doi: 10.1007/s10741-018-9741-9.
3
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.经导管房间隔分流装置治疗射血分数保留的心力衰竭(REDUCE LAP-HF I [降低心力衰竭患者左心房压力]):一项 2 期、随机、假手术对照试验。
Circulation. 2018 Jan 23;137(4):364-375. doi: 10.1161/CIRCULATIONAHA.117.032094. Epub 2017 Nov 15.
4
Interatrial Shunt Devices.房间隔分流装置
Heart Fail Clin. 2024 Jan;20(1):61-69. doi: 10.1016/j.hfc.2023.05.003. Epub 2023 Jul 4.
5
Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.房间隔分流装置对射血分数保留心力衰竭患者生存和心力衰竭住院的影响。
ESC Heart Fail. 2019 Feb;6(1):62-69. doi: 10.1002/ehf2.12350. Epub 2018 Oct 11.
6
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).用于治疗心力衰竭的经导管房间隔分流装置:降低心力衰竭患者升高的左心房压力的随机试验(REDUCE LAP-HF I)的原理与设计
Circ Heart Fail. 2016 Jul;9(7). doi: 10.1161/CIRCHEARTFAILURE.116.003025.
7
Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience.经皮房间隔切开术用于治疗症状性心力衰竭患者的左心房至冠状窦分流:首例人体经验。
JACC Cardiovasc Interv. 2020 May 25;13(10):1236-1247. doi: 10.1016/j.jcin.2020.02.022.
8
Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.心力衰竭患者降低升高的左心房压力(Reduce LAP-HF)试验的原理与设计
J Card Fail. 2015 Jul;21(7):594-600. doi: 10.1016/j.cardfail.2015.05.008. Epub 2015 Jun 6.
9
InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.房间隔分流装置(IASD®)植入术——一种治疗射血分数保留的心力衰竭的新方法。
Kardiol Pol. 2017;75(8):736-741. doi: 10.5603/KP.a2017.0096. Epub 2017 May 25.
10
Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device.通过单向左向右心房分流进行左心房减压治疗左心衰竭:V-Wave装置的首例人体经验
EuroIntervention. 2015 Jan;10(9):1127-31. doi: 10.4244/EIJY14M05_07.

引用本文的文献

1
Atrial Shunt Therapy for Heart Failure: An Update.心力衰竭的心房分流治疗:最新进展
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101203. doi: 10.1016/j.jscai.2023.101203. eCollection 2023 Nov-Dec.
2
Late Outcome of a Left-Atrial-to-Coronary-Sinus Shunt.左心房至冠状窦分流术的远期结果
JACC Case Rep. 2023 Oct 6;26:102039. doi: 10.1016/j.jaccas.2023.102039. eCollection 2023 Nov 15.
3
Structural Interventions in Heart Failure: Mending a Broken Heart.心力衰竭的结构性干预:修复破碎的心。
J Clin Med. 2023 May 1;12(9):3243. doi: 10.3390/jcm12093243.
4
Novel approaches for left atrial pressure relief: Device-based monitoring and management in heart failure.缓解左心房压力的新方法:心力衰竭中基于设备的监测与管理
Front Cardiovasc Med. 2022 Aug 11;9:910957. doi: 10.3389/fcvm.2022.910957. eCollection 2022.
5
Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future.儿童射血分数保留型心力衰竭(HFpEF)的治疗方法:现状与未来。
Paediatr Drugs. 2022 May;24(3):235-246. doi: 10.1007/s40272-022-00508-z. Epub 2022 May 2.
6
Exploring the Causal Effects of Circulating ST2 and Galectin-3 on Heart Failure Risk: A Mendelian Randomization Study.探索循环ST2和半乳糖凝集素-3对心力衰竭风险的因果效应:一项孟德尔随机化研究。
Front Cardiovasc Med. 2022 Apr 11;9:868749. doi: 10.3389/fcvm.2022.868749. eCollection 2022.
7
Clinical study on the treatment of chronic heart failure with a novel D-shant atrium shunt device.新型 D-Shunt 心房分流装置治疗慢性心力衰竭的临床研究。
ESC Heart Fail. 2022 Jun;9(3):1713-1720. doi: 10.1002/ehf2.13842. Epub 2022 Feb 18.
8
Impact of atrial flow regulator (AFR) implantation on 12-month mortality in heart failure : Insights from a single site in the PRELIEVE study.心房流调节装置(AFR)植入对心力衰竭 12 个月死亡率的影响:来自 PRELIEVE 研究的单中心观察。
Herz. 2022 Aug;47(4):366-373. doi: 10.1007/s00059-021-05063-w. Epub 2021 Aug 30.